Venturi Wealth Management LLC bought a new stake in shares of Perrigo Company plc (NYSE:PRGO – Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 2,131 shares of the company’s stock, valued at approximately $56,000.
A number of other large investors have also recently added to or reduced their stakes in PRGO. Beach Investment Counsel Inc. PA acquired a new stake in shares of Perrigo during the 2nd quarter valued at $72,000. Voisard Asset Management Group Inc. lifted its holdings in shares of Perrigo by 520.0% during the second quarter. Voisard Asset Management Group Inc. now owns 4,650 shares of the company’s stock valued at $119,000 after purchasing an additional 3,900 shares during the last quarter. Atria Investments Inc acquired a new position in shares of Perrigo in the 3rd quarter valued at $208,000. CWM LLC increased its stake in Perrigo by 877.0% in the 2nd quarter. CWM LLC now owns 8,197 shares of the company’s stock worth $210,000 after purchasing an additional 7,358 shares in the last quarter. Finally, Sanctuary Advisors LLC purchased a new stake in Perrigo during the second quarter valued at about $213,000. 95.91% of the stock is currently owned by institutional investors.
Perrigo Stock Performance
Shares of PRGO opened at $26.81 on Friday. Perrigo Company plc has a 52 week low of $23.89 and a 52 week high of $34.60. The company has a debt-to-equity ratio of 0.94, a quick ratio of 1.77 and a current ratio of 2.56. The company has a market capitalization of $3.66 billion, a PE ratio of -22.91 and a beta of 0.48. The company’s 50 day moving average price is $25.96 and its 200 day moving average price is $27.33.
Perrigo Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Friday, November 29th will be issued a $0.276 dividend. The ex-dividend date of this dividend is Friday, November 29th. This represents a $1.10 dividend on an annualized basis and a yield of 4.12%. Perrigo’s dividend payout ratio is currently -94.02%.
Insider Activity at Perrigo
In other news, Director Katherine C. Doyle sold 8,954 shares of the firm’s stock in a transaction on Friday, September 13th. The shares were sold at an average price of $27.30, for a total transaction of $244,444.20. Following the transaction, the director now owns 6,009 shares in the company, valued at approximately $164,045.70. This trade represents a 59.84 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Ronald Craig Janish sold 13,000 shares of Perrigo stock in a transaction on Monday, August 26th. The shares were sold at an average price of $29.40, for a total transaction of $382,200.00. Following the completion of the sale, the executive vice president now directly owns 20,553 shares of the company’s stock, valued at approximately $604,258.20. The trade was a 38.74 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 50,254 shares of company stock valued at $1,411,969. 0.70% of the stock is currently owned by corporate insiders.
Wall Street Analysts Forecast Growth
Several research analysts have recently weighed in on PRGO shares. Jefferies Financial Group reissued a “hold” rating and issued a $30.00 target price (down from $50.00) on shares of Perrigo in a research report on Monday, September 23rd. StockNews.com upgraded shares of Perrigo from a “hold” rating to a “buy” rating in a research report on Thursday, November 7th. Finally, Canaccord Genuity Group restated a “buy” rating and issued a $42.00 target price on shares of Perrigo in a report on Monday, September 30th. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat, Perrigo currently has an average rating of “Moderate Buy” and a consensus target price of $37.00.
Get Our Latest Report on Perrigo
Perrigo Company Profile
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.
Featured Articles
- Five stocks we like better than Perrigo
- What Investors Need to Know to Beat the Market
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Top-Performing Non-Leveraged ETFs This Year
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Want to see what other hedge funds are holding PRGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Perrigo Company plc (NYSE:PRGO – Free Report).
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.